Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

HNE inhibitors prepared at Glaxo Wellcome

Dec. 24, 1997

Neurokinin antagonists in the pipeline at Schering-Plough

Dec. 23, 1997

Schering-Plough obtains rights to Claritin metabolite from Sepracor

Dec. 22, 1997

Vyrex's respiratory antioxidant shows potential as asthma therapy

Dec. 22, 1997

Patient enrollment completed for ARDS phase Ib trial

Dec. 18, 1997

Singulair available in Mexico for asthma

Dec. 17, 1997

Atopy associated with IL-4R mutation; findings support Immunex's development of soluble IL-4R

Dec. 15, 1997

Yamanouchi describes development of dual NK1/NK2 antagonist

Dec. 15, 1997

Long-term asthma therapy options compared in children

Dec. 15, 1997

Alza and Warner-Lambert sign distribution agreement for nasal decongestant OTC

Dec. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...